One year after its initial public offering, Helix Acquisition Corp. II is now helping another biotech company go public.

The deal comes amid an uptick in so-called SPAC deals, which had fallen out of favor due to poor returns and increased ...

In a move straight out of 2021, BridgeBio Oncology is taking the SPAC route to the public markets in a deal with Helix ...

BridgeBio Pharma (BBIO) stock in focus as its 2024 spinout BridgeBio Oncology merges with Helix to form go public on Nasdaq ...

Rithm Acquisition Corp. is selling 20 million units of combined stock and warrants for $10 each, with trading expected to ...

The Saratoga Performing Arts Center (SPAC) has announced the appointment of Jana Gordon as its new Senior Vice President of ...

Seattle's Nautilus Biotechnology is laying off 16% of workforce, and plans to release its commercial platform in late 2026.

Trump Media plans to reincorporate in Florida for tax breaks and a favorable business climate, aiming to protect against ...

Horizon focuses on the software infrastructure for quantum computing, which the company says sets it apart from D-Wave ...

Julie Young is an experienced financial writer and editor. She specializes in financial analysis in capital planning and investment management. Samantha (Sam) Silberstein, CFP®, CSLP®, EA, is an ...

Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...